Real Estate - Services
Compare Stocks
5 / 10Stock Comparison
LGPS vs WELL vs VTR vs LPSN vs OHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Software - Application
REIT - Healthcare Facilities
LGPS vs WELL vs VTR vs LPSN vs OHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Software - Application | REIT - Healthcare Facilities |
| Market Cap | $17M | $149.25B | $41.15B | $32M | $13.74B |
| Revenue (TTM) | $10.20B | $11.63B | $6.13B | $244M | $1.24B |
| Net Income (TTM) | $387M | $1.43B | $260M | $-67M | $632M |
| Gross Margin | 17.8% | 39.1% | -4.3% | 62.2% | 85.5% |
| Operating Margin | 6.6% | 4.4% | 13.4% | -9.6% | 64.3% |
| Forward P/E | 3.1x | 78.4x | 118.0x | — | 23.4x |
| Total Debt | $17.38B | $21.38B | $13.22B | $392M | $4.26B |
| Cash & Equiv. | $2.12B | $5.03B | $741M | $95M | $27M |
LGPS vs WELL vs VTR vs LPSN vs OHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 25 | May 26 | Return |
|---|---|---|---|
| LogProstyle Inc. (LGPS) | 100 | 23.6 | -76.4% |
| Welltower Inc. (WELL) | 100 | 139.0 | +39.0% |
| Ventas, Inc. (VTR) | 100 | 125.9 | +25.9% |
| LivePerson, Inc. (LPSN) | 100 | 22.4 | -77.6% |
| Omega Healthcare In… (OHI) | 100 | 121.1 | +21.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LGPS vs WELL vs VTR vs LPSN vs OHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LGPS has the current edge in this matchup, primarily because of its strength in growth and value.
- 46.2% FFO/revenue growth vs LPSN's -22.0%
- Lower P/E (3.1x vs 23.4x)
WELL is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 223.1% 10Y total return vs OHI's 110.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- 1.3% yield, 2-year raise streak, vs OHI's 5.4%, (2 stocks pay no dividend)
VTR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01 vs LPSN's 2.05
Among these 5 stocks, LPSN doesn't own a clear edge in any measured category.
OHI ranks third and is worth considering specifically for quality and efficiency.
- 51.0% margin vs LPSN's -27.6%
- 6.1% ROA vs LPSN's -12.4%, ROIC 6.0% vs -6.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.2% FFO/revenue growth vs LPSN's -22.0% | |
| Value | Lower P/E (3.1x vs 23.4x) | |
| Quality / Margins | 51.0% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.01 vs LPSN's 2.05 | |
| Dividends | 1.3% yield, 2-year raise streak, vs OHI's 5.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +42.7% vs LGPS's -85.2% | |
| Efficiency (ROA) | 6.1% ROA vs LPSN's -12.4%, ROIC 6.0% vs -6.6% |
LGPS vs WELL vs VTR vs LPSN vs OHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LGPS vs WELL vs VTR vs LPSN vs OHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 1 of 6 categories
LGPS leads 1 • WELL leads 1 • VTR leads 0 • LPSN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 47.7x LPSN's $244M. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $10.2B | $11.6B | $6.1B | $244M | $1.2B |
| EBITDAEarnings before interest/tax | $768M | $2.8B | $2.3B | -$562,000 | $1.1B |
| Net IncomeAfter-tax profit | $387M | $1.4B | $260M | -$67M | $632M |
| Free Cash FlowCash after capex | -$1.1B | $2.5B | $1.4B | -$43M | $912M |
| Gross MarginGross profit ÷ Revenue | +17.8% | +39.1% | -4.3% | +62.2% | +85.5% |
| Operating MarginEBIT ÷ Revenue | +6.6% | +4.4% | +13.4% | -9.6% | +64.3% |
| Net MarginNet income ÷ Revenue | +3.8% | +12.3% | +4.2% | -27.6% | +51.0% |
| FCF MarginFCF ÷ Revenue | -10.6% | +21.9% | +22.4% | -17.4% | +73.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +23.4% | +40.3% | +22.0% | -19.0% | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +37.4% | +22.5% | 0.0% | +79.4% | +42.4% |
Valuation Metrics
LGPS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 3.1x trailing earnings, LGPS trades at a 98% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, LGPS's 12.0x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $17M | $149.2B | $41.1B | $32M | $13.7B |
| Enterprise ValueMkt cap + debt − cash | $114M | $165.6B | $53.6B | $329M | $18.0B |
| Trailing P/EPrice ÷ TTM EPS | 3.15x | 153.25x | 160.26x | -0.22x | 23.78x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 118.01x | — | 23.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.02x |
| EV / EBITDAEnterprise value multiple | 12.00x | 66.40x | 24.31x | — | 16.72x |
| Price / SalesMarket cap ÷ Revenue | 0.13x | 13.99x | 7.05x | 0.13x | 11.47x |
| Price / BookPrice ÷ Book value/share | 0.67x | 3.35x | 3.18x | — | 2.63x |
| Price / FCFMarket cap ÷ FCF | 3.46x | 52.41x | 31.25x | — | 15.64x |
Profitability & Efficiency
Evenly matched — LGPS and OHI each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for VTR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to LGPS's 4.94x. On the Piotroski fundamental quality scale (0–9), LGPS scores 7/9 vs LPSN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.0% | +3.5% | +2.1% | — | +11.9% |
| ROA (TTM)Return on assets | +1.7% | +2.3% | +1.0% | -12.4% | +6.1% |
| ROICReturn on invested capital | +5.4% | +0.5% | +2.5% | -6.6% | +6.0% |
| ROCEReturn on capital employed | +10.6% | +0.6% | +3.2% | -5.8% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 4.94x | 0.49x | 1.05x | — | 0.78x |
| Net DebtTotal debt minus cash | $15.3B | $16.3B | $12.5B | $297M | $4.2B |
| Cash & Equiv.Liquid assets | $2.1B | $5.0B | $741M | $95M | $27M |
| Total DebtShort + long-term debt | $17.4B | $21.4B | $13.2B | $392M | $4.3B |
| Interest CoverageEBIT ÷ Interest expense | 6.39x | 0.26x | 1.40x | 0.20x | 3.83x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $35 for LPSN. Over the past 12 months, WELL leads with a +42.7% total return vs LGPS's -85.2%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs LPSN's -65.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -29.1% | +14.3% | +12.6% | -31.1% | +6.6% |
| 1-Year ReturnPast 12 months | -85.2% | +42.7% | +33.9% | -77.1% | +36.9% |
| 3-Year ReturnCumulative with dividends | -80.5% | +189.5% | +94.2% | -95.8% | +86.2% |
| 5-Year ReturnCumulative with dividends | -80.5% | +202.3% | +74.8% | -99.7% | +63.1% |
| 10-Year ReturnCumulative with dividends | -80.5% | +223.1% | +65.0% | -97.0% | +110.0% |
| CAGR (3Y)Annualised 3-year return | -42.0% | +42.5% | +24.8% | -65.4% | +23.0% |
Risk & Volatility
Evenly matched — VTR and OHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs LGPS's 9.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.01x | 0.13x | 0.01x | 2.05x | -0.13x |
| 52-Week HighHighest price in past year | $7.20 | $219.59 | $88.50 | $21.60 | $49.14 |
| 52-Week LowLowest price in past year | $0.45 | $142.65 | $61.76 | $2.37 | $35.09 |
| % of 52W HighCurrent price vs 52-week peak | +9.7% | +97.0% | +97.8% | +12.4% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 47.6 | 60.2 | 56.2 | 40.3 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 28K | 2.6M | 3.4M | 148K | 1.9M |
Analyst Outlook
Evenly matched — WELL and OHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", VTR as "Buy", OHI as "Hold". Consensus price targets imply 6.5% upside for OHI (target: $49) vs 4.9% for VTR (target: $91). For income investors, OHI offers the higher dividend yield at 5.44% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — | Hold |
| Price TargetConsensus 12-month target | — | $226.50 | $90.80 | — | $49.14 |
| # AnalystsCovering analysts | — | 34 | 32 | — | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +2.1% | — | +5.4% |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | — | 0 |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.86 | — | $2.51 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
OHI leads in 1 of 6 categories (Income & Cash Flow). LGPS leads in 1 (Valuation Metrics). 3 tied.
LGPS vs WELL vs VTR vs LPSN vs OHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LGPS or WELL or VTR or LPSN or OHI a better buy right now?
For growth investors, LogProstyle Inc.
(LGPS) is the stronger pick with 46. 2% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). LogProstyle Inc. (LGPS) offers the better valuation at 3. 1x trailing P/E, making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LGPS or WELL or VTR or LPSN or OHI?
On trailing P/E, LogProstyle Inc.
(LGPS) is the cheapest at 3. 1x versus Ventas, Inc. at 160. 3x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 23. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — LGPS or WELL or VTR or LPSN or OHI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: WELL returned +223. 1% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LGPS or WELL or VTR or LPSN or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately -1700% more volatile than OHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 5% for LogProstyle Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — LGPS or WELL or VTR or LPSN or OHI?
By revenue growth (latest reported year), LogProstyle Inc.
(LGPS) is pulling ahead at 46. 2% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LGPS or WELL or VTR or LPSN or OHI?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — LPSN leads at 62. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LGPS or WELL or VTR or LPSN or OHI more undervalued right now?
On forward earnings alone, Omega Healthcare Investors, Inc.
(OHI) trades at 23. 4x forward P/E versus 118. 0x for Ventas, Inc. — 94. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OHI: 6. 5% to $49. 14.
08Which pays a better dividend — LGPS or WELL or VTR or LPSN or OHI?
In this comparison, OHI (5.
4% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. LGPS, LPSN do not pay a meaningful dividend and should not be held primarily for income.
09Is LGPS or WELL or VTR or LPSN or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OHI: +110. 0%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LGPS and WELL and VTR and LPSN and OHI?
These companies operate in different sectors (LGPS (Real Estate) and WELL (Real Estate) and VTR (Real Estate) and LPSN (Technology) and OHI (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LGPS is a small-cap high-growth stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; LPSN is a small-cap quality compounder stock; OHI is a mid-cap income-oriented stock. WELL, VTR, OHI pay a dividend while LGPS, LPSN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.